Apparently one company has been issued a patent which basically says if you want to get tested for breast of ovarian cancer, tough! You will need to fork over $3000 for Myriad Genetics.
Seriously the patents at issue give Myriad Genetics a virtual monopoly on such predictive testing for breast and ovarian cancer.
I wonder when people will wake up and see what is going on here. I am glad the courts are intervening. See Wired for the whole story.